A controlled clinical trial of trimethoprim-sulphamethoxazole in shigella dysentery.
D000293:Adolescent; D000328:Adult; D000667:Ampicillin / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D002986:Clinical Trials as Topic; D003681:Dehydration / Q000188:drug therapy; D004338:Drug Combinations; D004405:Dysentery, Bacillary / Q000188:drug therapy*; D005260:Female; D005334:Fever / Q000188:drug therapy; D006801:Humans; D008297:Male; D008551:Melena / Q000188:drug therapy; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010146:Pain; D012760:Shigella / Q000187:drug effects; D012761:Shigella boydii / Q000302:isolation & purification; D012762:Shigella dysenteriae / Q000302:isolation & purification; D012763:Shigella flexneri / Q000302:isolation & purification; D013307:Streptomycin / Q000494:pharmacology; D013418:Sulfamethazine / Q000627:therapeutic use; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D013752:Tetracycline / Q000494:pharmacology; D014295:Trimethoprim / Q000627:therapeutic use*; D014839:Vomiting / Q000188:drug therapy
D004338:Drug Combinations; D013418:Sulfamethazine; D002701:Chloramphenicol; D000667:Ampicillin; D014295:Trimethoprim; D013752:Tetracycline; D013420:Sulfamethoxazole; D013307:Streptomycin